Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Settles 16-Year Cipro Pay-For-Delay Litigation For $225M; Will Focus Shift To Pricing Deals?

Executive Summary

California indirect purchasers reached previous settlements with Bayer and three other firms; plaintiffs’ attorney sees shift from reverse-payment to price fixing and market swapping cases. Trump appointments to FTC could influence direction of scrutiny.

Advertisement

Related Content

FTC Focus On Pay-For-Delay Deals Continues; Endo Agrees To 10-Year Abstention
Generic Price Fixing Probe: First Charges Unsealed, More May Come Before Inauguration Day
Teva’s Pay-For-Delay Settlement Restricts Brand-Generic Deals
‘Pay-For-Delay’ Deals Likely Put On Hold Themselves After Cipro Ruling
Teva Settles Provigil Pay-For-Delay Class Action; Will FTC Deal Follow?
Patent Settlements: 2nd Circuit Okays Bayer's Cipro Deal But Doesn't Want To

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS119929

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel